In-Depth Insights into the Peptide Therapeutics Market: Growth, Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the peptide therapeutics market right now?
The size of the peptide therapeutics market has experienced rapid expansion in the past few years. This market, which was evaluated at $45.15 billion in 2024, is anticipated to generate revenues worth $49.67 billion in 2025, depicting a Compound annual growth rate (CAGR) of 10.0%. The surge witnessed during the historic phase can be credited to a rise in chronic disease incidences, a better grasp of molecular biology, and wider applications in the field of oncology.
How fast Is the peptide therapeutics market expected to grow, and what’s its future value?
Get your peptide therapeutics market report here!
https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report
What are the leading drivers of growth in the peptide therapeutics market?
Expectations for the peptide therapeutics market’s growth are being driven by an upsurge in chronic diseases. These often incurable and lasting illnesses can occasionally be managed or cured. Contributors to the rise in chronic diseases include the increasing usage of tobacco, subpar nutrition, sedentariness, excessive consumption of alcohol, among others. Peptide therapeutics presents a viable solution for mitigating and treating certain chronic diseases. For instance, the National Library of Medicine, a US entity, projected in January 2023 that the population of US residents aged 50 and above suffering from a minimum of one chronic ailment would see a 99.5% surge, equating to 142.66 million individuals by 2050. Consequently, the peptide therapeutics market’s growth is anticipated to be spurred by the rising prevalence of chronic diseases during the projected timeframe.
What are the key segments defining the peptide therapeutics market?
The peptide therapeutics market covered in this report is segmented –
1) By Type: Generic, Branded
2) By Route of Administration: Parenteral, Mucosal, Oral, Transdermal
3) By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications
Subsegments:
1) By Generic: Generic Peptide Drugs, Biosimilars
2) By Branded: Innovative Peptide Drugs, Patent-Protected Peptides
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp
Who are the key players steering the development of the peptide therapeutics market?
Major companies operating in the peptide therapeutics market include Pfizer Inc., Jhonson & Jhonson, Abbvie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk AS, Teva Pharmaceuticals Industries Ltd., Bachem Holding AG, PolyPeptide Laboratories BV, Arcus Biosciences Inc., Pepscan Therapeutics, Peptech Inc., Peptide Logic Inc., SELLAS Life Sciences Group, Ever Neuro Pharma GmbH, Zealand Pharma AG, PepGen Inc., Pepticom S.A., Peptide Technologies Corporation, SynPeptide Inc., Peptimmune Inc., Merck & Co Inc.
What emerging trends are influencing the growth of the peptide therapeutics market?
Pfizer Inc., Jhonson & Jhonson, Abbvie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk AS, Teva Pharmaceuticals Industries Ltd, Bachem Holding AG, PolyPeptide Laboratories BV, Arcus Biosciences Inc., Pepscan Therapeutics, Peptech Inc., Peptide Logic Inc., SELLAS Life Sciences Group, Ever Neuro Pharma GmbH, Zealand Pharma AG, PepGen Inc., Pepticom S.A., Peptide Technologies Corporation, SynPeptide Inc., Peptimmune Inc., Merck & Co Inc are the major players in the peptide therapeutics market.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7216
Which regions are most influential in expanding the peptide therapeutics market?
North America was the largest region in the peptide therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Biosimilar Therapeutic Peptides Global Market Report 2024
Nutritional Feed Additives Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/nutritional-feed-additives-global-market-report
Peptide Antibiotics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
